{
    "root": "0ea3269c-c917-4b90-8fa1-604c53299ada",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "escitalopram",
    "value": "20250501",
    "ingredients": [
        {
            "name": "ESCITALOPRAM OXALATE",
            "code": "5U85DBW7LO"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "POVIDONE, UNSPECIFIED",
            "code": "FZ989GH94E"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "HYPROMELLOSE 2910 (6 MPA.S)",
            "code": "0WZ8WG20P6"
        },
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        }
    ],
    "indications": "escitalopram selective serotonin reuptake inhibitor ( ssri ) indicated : • treatment major depressive disorder ( mdd ) adults pediatric patients 12 years age older ( 1 ) • treatment generalized anxiety disorder ( gad ) adults ( 1 )",
    "contraindications": "indication population recommended mdd adults ( 2.1 ) initial : 10 mg daily recommended : 10 mg daily maximum : 20 mg daily mdd pediatric patients 12 years older ( 2.1 ) initial : 10 mg daily recommended : 10 mg daily maximum : 20 mg daily gad adults ( 2.2 ) initial : 10 mg daily recommended : 10 mg daily maximum : 20 mg daily • additional benefits seen 20 mg daily ( 2.1 ) • administer daily , morning evening , without food ( 2.3 ) • elderly patients : recommended 10 mg daily ( 2.4 ) • hepatic impairment : recommended 10 mg daily ( 2.4 , 8.6 ) • discontinuing escitalopram tablets , reduce dose gradually whenever possible ( 2.5 )",
    "warningsAndPrecautions": null,
    "adverseReactions": "• maois intended treat psychiatric disorders escitalopram within 14 days stopping treatment escitalopram . escitalopram within 14 days stopping maoi intended treat psychiatric disorders . addition , start escitalopram patient treated linezolid intravenous methylene blue ( 4 ) • concomitant pimozide ( 4 ) • known hypersensitivity escitalopram citalopram inactive ingredients ( 4 )",
    "indications_original": "Escitalopram is a selective serotonin reuptake inhibitor (SSRI) indicated for the: • treatment of major depressive disorder (MDD) in adults and pediatric patients 12 years of age and older ( 1 ) • treatment of generalized anxiety disorder (GAD) in adults ( 1 )",
    "contraindications_original": "Indication and Population Recommended Dosage MDD in Adults ( 2.1 ) Initial: 10 mg once daily Recommended: 10 mg once daily Maximum: 20 mg once daily MDD in Pediatric Patients 12 years and older ( 2.1 ) Initial: 10 mg once daily Recommended: 10 mg once daily Maximum: 20 mg once daily GAD in Adults ( 2.2 ) Initial: 10 mg once daily Recommended: 10 mg once daily Maximum: 20 mg once daily • No additional benefits were seen at 20 mg once daily ( 2.1 ) • Administer once daily, morning or evening, with or without food ( 2.3 ) • Elderly patients: recommended dosage is 10 mg once daily ( 2.4 ) • Hepatic impairment: recommended dosage is 10 mg once daily ( 2.4 , 8.6 ) • When discontinuing Escitalopram tablets, reduce dose gradually whenever possible ( 2.5 )",
    "adverseReactions_original": "• Do not use MAOIs intended to treat psychiatric disorders with escitalopram or within 14 days of stopping treatment with escitalopram. Do not use escitalopram within 14 days of stopping an MAOI intended to treat psychiatric disorders. In addition, do not start escitalopram in a patient who is being treated with linezolid or intravenous methylene blue ( 4 ) • Concomitant use of pimozide ( 4 ) • Known hypersensitivity to escitalopram or citalopram or any of the inactive ingredients ( 4 )"
}